-
Mashup Score: 43FDA approves alectinib as adjuvant treatment - 1 month(s) ago
FDA approves alectinib as adjuvant treatment for ALK-positive non-small cell lung cancer.
Source: www.fda.govCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 41FDA approves alectinib as adjuvant treatment - 1 month(s) ago
FDA approves alectinib as adjuvant treatment for ALK-positive non-small cell lung cancer.
Source: www.fda.govCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 41FDA approves alectinib as adjuvant treatment - 1 month(s) ago
FDA approves alectinib as adjuvant treatment for ALK-positive non-small cell lung cancer.
Source: www.fda.govCategories: General Medicine News, Onc News and JournalsTweet
FDA approved alectinib for adjuvant treatment following tumor resection in patients with ALK-positive non-small cell lung cancer, as detected by an FDA-approved test. https://t.co/VE7XZzBXeo #OCENewsBurst #lcsm #nsclc